IM Cannabis Corp. Common Shares (IMCC) — Analysis Summary
IM Cannabis Corp. Common Shares (IMCC) has a market cap of $2.06M with year-over-year revenue growth of -0.5%. Net margin stands at -21.5%. The stock trades at a P/E ratio of -0.2.
Key Takeaways
- Revenue changed -0.5% year-over-year
- Net margin of -21.5%
- P/E ratio of -0.2
Compared with its sector, IMCC posted revenue growth of -0.5% and trades at a P/E of -0.2.
IM Cannabis Corp. Common Shares (IMCC)
UPDATED — ET · MARKET DATA POLYGON · FINANCIALS SEC EDGAR
Red Flags & WarningsHigh Risk Signals
Multiple material red flags are active and deserve closer underwriting before relying on any valuation output.
Interest coverage at -3.3x — earnings do not cover interest payments
Shareholder equity is negative, which can signal balance-sheet stress.
Current ratio at 0.67x — current liabilities exceed current assets
Operating margin at -21.2% — material operating losses
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority revenue is generated from Germany, and also has its presence in Israel.
Employees
44
Exchange
XNAS
Systematic competitive advantage assessment based on 4yr data
This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.
First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.
Capital Structure
Cash Flow
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.